Author response for "Semaglutide and Cardiovascular Risk in Type 1 Diabetes: A Predictive Modeling Analysis in a Double-Blind, Randomized, Placebo-Controlled Cross-Over Trial"

2026

View at publisher
Authors: Luxcia Kugathasan, Michael A. Tsoukas, Massimo Nardone, Vikas S. Sridhar, Marcel H.A. Muskiet, David Z.I. Cherney, Ahmad Haidar, Melissa‐Rosina Pasqua
DOI: 10.1111/dom.70525/v2/response1
Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Publication date
19 January 2026